{
  "id": "short-chain-fatty-acid",
  "title": "Short-Chain Fatty Acid",
  "lang": "en",
  "source_lang": "en",
  "summary": "Short-chain fatty acids are small carboxylic acids produced chiefly by microbial fermentation, with important metabolic, signaling, agricultural, and industrial roles.",
  "category": "science",
  "subcategory": "chemistry",
  "type": "concept",
  "aliases": [
    "Short-chain fatty acids",
    "SCFAs"
  ],
  "generated_at": "2026-11-06",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/short-chain-fatty-acid/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/short-chain-fatty-acid/",
      "json": "https://aiwiki.page/zh/short-chain-fatty-acid.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Short-chain fatty acids (SCFAs) are small organic acids conventionally defined as fatty acids containing fewer than six carbon atoms, although some classifications include six-carbon compounds. Acetate, propionate, and butyrate are the principal SCFAs studied in mammalian intestinal biology. They are produced largely through microbial fermentation of carbohydrates and other substrates, then used by microorganisms and host tissues as metabolic fuels, biosynthetic precursors, and signaling molecules.\n\nSCFAs connect the activities of the gut microbiota with the physiology of the intestinal epithelium, liver, immune system, and other organs. Their effects depend on which acid is present, its concentration, where it is produced, and how rapidly it is absorbed and metabolized. A concentration measured in feces therefore does not directly describe either microbial production or exposure elsewhere in the body.\n\nOutside human physiology, these acids are central to ruminant nutrition, anaerobic decomposition, wastewater treatment, food preservation, and industrial biotechnology. Their importance rests on a shared chemical property: a small carboxyl group attached to a short carbon skeleton makes them readily exchangeable intermediates between microbial communities and their surroundings."
    },
    {
      "heading": "Chemical identity and classification",
      "text": "The central members of the SCFA group are acetic acid, with two carbon atoms; propionic acid, with three; and butyric acid, with four. Their formulas are respectively \\(\\mathrm{CH_3COOH}\\), \\(\\mathrm{CH_3CH_2COOH}\\), and \\(\\mathrm{CH_3CH_2CH_2COOH}\\). Pentanoic acid, usually called valeric acid, is another member. Formic acid is sometimes included in operational definitions of short-chain organic acids, although it lacks the alkyl group characteristic of the larger members. Six-carbon hexanoic, or caproic, acid lies at a variable boundary between short- and medium-chain classifications. Consequently, a study’s explicit definition is more informative than the abbreviation alone.\n\nStraight-chain acids dominate discussions of carbohydrate fermentation, but branched-chain forms also occur. Isobutyrate, isovalerate, and 2-methylbutyrate are particularly associated with microbial breakdown of the amino acids valine, leucine, and isoleucine, respectively. These compounds are commonly grouped as branched-chain fatty acids. Their abundance can help characterize fermentation patterns, but it is not a unique measure of dietary protein intake because microbial reuse, intestinal absorption, and substrate availability also affect their concentrations. Lactate and succinate, although important fermentation intermediates, are generally treated separately from the principal SCFAs because they are respectively a hydroxy acid and a dicarboxylic acid.\n\nEach SCFA contains a carboxyl group that can lose a proton. The distinction between “acetic acid” and “acetate,” for example, is an acid–base distinction rather than a difference in the carbon skeleton. The relevant relationship is\n\n\\[\\mathrm{RCOOH \\rightleftharpoons RCOO^- + H^+}.\\]\n\nFor acetate, propionate, and butyrate, acid dissociation constants correspond to \\(pK_a\\) values near 4.8. Their ionization is therefore strongly influenced by pH. The Henderson–Hasselbalch relationship expresses this dependence:\n\n\\[\\mathrm{pH}=pK_a+\\log_{10}\\frac{[\\mathrm{RCOO^-}]}{[\\mathrm{RCOOH}]}.\\]\n\nAt pH 7, more than 99% is present as the negatively charged carboxylate. Even in the mildly acidic large intestine, the ionized form predominates, although the smaller undissociated fraction remains important for membrane passage and antimicrobial activity. Biological literature often uses acid and anion names interchangeably when referring to the total pool.\n\nThese compounds are relatively soluble in water, especially at shorter chain lengths, and their free-acid forms have characteristic sharp or rancid odors. Their volatility under suitable analytical and processing conditions explains the widely used term “volatile fatty acids.” Volatility is nevertheless dependent on ionization, temperature, and the sample matrix; a dissolved sodium carboxylate is not equivalent in handling or headspace behavior to the corresponding free acid."
    },
    {
      "heading": "Microbial formation and metabolic exchange",
      "text": "In the human large intestine, SCFAs arise mainly from microbial processing of dietary fiber, resistant starch, and other carbohydrates that escape digestion in the small intestine. Host-derived materials, including mucus glycans, also provide substrates. Fermentation allows anaerobic microorganisms to conserve energy and balance reducing equivalents without relying on oxygen as the terminal electron acceptor. The resulting products depend on the starting substrate, the organisms present, and environmental conditions such as pH and hydrogen availability.\n\nAcetate is produced by a particularly broad range of bacteria. A common route converts sugars through glycolysis to pyruvate and then acetyl-coenzyme A, or acetyl-CoA. Conversion through acetyl phosphate to acetate can generate ATP by substrate-level phosphorylation. Some anaerobes instead form acetate from carbon dioxide and hydrogen through the Wood–Ljungdahl pathway. Thus, acetate production can reflect both carbohydrate breakdown and the recycling of products released by other microorganisms.\n\nPropionate production follows several distinct biochemical routes. In the succinate pathway, carbon flows through intermediates related to oxaloacetate, succinate, and methylmalonyl-CoA before forming propionyl-CoA and propionate. This route occurs in many members of the Bacteroidota. The acrylate pathway converts lactate into propionate in certain bacteria, whereas the propanediol pathway uses substrates derived from deoxy sugars such as fucose and rhamnose. These alternatives help explain why different diets and microbial communities can yield similar end products through different metabolic networks.\n\nButyrate commonly forms by condensation of two acetyl-CoA molecules, followed by reactions leading through acetoacetyl-CoA and butyryl-CoA. In many abundant human intestinal butyrate producers, the final reaction is catalyzed by butyryl-CoA:acetate CoA-transferase, which consumes acetate while releasing butyrate. A different route uses phosphotransbutyrylase and butyrate kinase. Well-studied producers include Faecalibacterium prausnitzii, Eubacterium rectale, and several Roseburia species, although production varies among strains and growth conditions.\n\nThese pathways operate within networks of microbial cross-feeding. One organism may release oligosaccharides from a complex polysaccharide, another may ferment the sugars to lactate and acetate, and a third may convert those products to butyrate. Certain bifidobacteria, for example, can support butyrate production indirectly even though they are not themselves major butyrate producers. The presence of an organism therefore cannot be translated directly into a fixed quantity of one metabolite.\n\nSubstrate supply and intestinal transit shape this ecology. Readily fermentable carbohydrate is often consumed preferentially in the proximal colon, whereas distal communities may depend more heavily on remaining complex substrates and host secretions. When carbohydrate becomes limiting, amino-acid fermentation can contribute both straight-chain and branched-chain acids, alongside products such as ammonia and phenolic compounds. SCFA composition consequently reflects a community’s combined metabolic activity rather than a simple inventory of “beneficial” and “harmful” organisms."
    },
    {
      "heading": "Intestinal absorption and distribution through the body",
      "text": "SCFAs are produced primarily in the intestinal lumen but are extensively absorbed before fecal material is excreted. Human colonic contents commonly contain total concentrations in the range of tens to more than 100 millimoles per liter, with substantial variation among locations, individuals, diets, and sampling methods. Acetate is usually the most abundant, followed by propionate and butyrate. A molar ratio near 60:20:20 is often used as an illustrative approximation, not as a physiological constant.\n\nAbsorption combines several processes. The undissociated acid can cross the cell membrane by passive diffusion, while the anion is transported by specialized proteins. Monocarboxylate transporter 1, encoded by SLC16A1, couples transport to protons. Sodium-coupled monocarboxylate transporter 1, encoded by SLC5A8, uses the sodium gradient to drive uptake. SCFA movement is therefore linked to ion gradients and intracellular pH regulation, not merely to concentration differences across a lipid membrane. Additional exchange and transport processes contribute to movement through the epithelium.\n\nThe three major acids have different metabolic fates. Butyrate is extensively oxidized by mature colonocytes, the absorptive epithelial cells of the colon. After activation to butyryl-CoA, its carbon can enter acetyl-CoA and the citric acid cycle, supporting mitochondrial energy production. Because the epithelium consumes a large proportion locally, the amount reaching portal blood is much smaller than its luminal production. This local use makes butyrate a prominent example of a microbial product that acts as both nutrient and regulator at its site of absorption.\n\nPropionate passes into the portal circulation and is substantially extracted by the liver. Its conversion through propionyl-CoA and methylmalonyl-CoA to succinyl-CoA permits entry into central metabolism. This pathway provides carbon that can support gluconeogenesis. Acetate undergoes less complete first-pass removal and is normally the most abundant SCFA in peripheral blood. It can be activated to acetyl-CoA in multiple tissues and used for oxidation or biosynthetic reactions, including lipid synthesis under appropriate metabolic conditions.\n\nLuminal, portal, and peripheral concentrations must therefore be distinguished. Peripheral acetate is commonly measured in the tens to low hundreds of micromoles per liter, whereas propionate and butyrate are generally much lower, often in the low micromolar range. Values depend on feeding state, sampling, analytical methods, and other physiological factors. Millimolar effects demonstrated in cultured cells cannot automatically be assigned to tissues exposed only to micromolar circulating concentrations.\n\nFecal SCFAs represent the residual balance of production, microbial consumption, host absorption, transit, and dilution by water. A low fecal concentration could accompany low production, but it could also reflect efficient absorption. Conversely, a high concentration may result from greater production, faster transit, or reduced uptake. Concentration alone is not a measure of the rate at which SCFA carbon enters host metabolism."
    },
    {
      "heading": "Receptors, enzyme inhibition, and cellular signaling",
      "text": "SCFAs act through several mechanisms that are related but experimentally distinguishable. They supply metabolic carbon, activate cell-surface receptors, alter intracellular acid–base conditions, and influence enzymes involved in chromatin regulation. The relative importance of each mechanism depends on the acid, cell type, dose, and duration of exposure. An effect abolished by blocking metabolism is not necessarily equivalent to an effect caused by receptor activation, even when both follow treatment with the same compound.\n\nTwo major receptors are free fatty acid receptor 2 and free fatty acid receptor 3, commonly abbreviated FFAR2 and FFAR3 and formerly called GPR43 and GPR41. Both belong to the G-protein-coupled receptor family. Acetate and propionate are prominent FFAR2 agonists, while propionate and butyrate generally activate FFAR3 more strongly than acetate. Relative potency varies with species and assay conditions. FFAR2 can couple to \\(G_{i/o}\\) and \\(G_{q/11}\\), influencing cyclic AMP and intracellular calcium signaling; FFAR3 primarily couples to \\(G_{i/o}\\).\n\nThese receptors occur in several relevant cell populations, including intestinal enteroendocrine cells and subsets of immune cells. Their activation can affect hormone secretion, migration, and inflammatory responses. Receptor distribution is not identical between humans and laboratory animals, and a receptor’s messenger RNA abundance does not by itself establish functional signaling. Experiments using receptor-deficient mice or selective agonists have helped separate receptor-dependent actions from the many other consequences of SCFA exposure.\n\nButyrate also activates hydroxycarboxylic acid receptor 2, known as HCAR2 or GPR109A. This receptor recognizes other ligands, including nicotinic acid and the ketone body beta-hydroxybutyrate. Its activation by butyrate generally requires concentrations more readily achieved in the colon than in peripheral blood. Receptor location and ligand concentration are therefore essential to interpreting its biological relevance.\n\nButyrate and, less potently, propionate can inhibit certain histone deacetylases. These enzymes remove acetyl groups from histones and other proteins. Inhibition can alter chromatin accessibility and gene expression, but the result is not a uniform increase in all transcription. Changes depend on the genes, transcription factors, and regulatory networks active in a particular cell. Butyrate-induced histone hyperacetylation was recognized experimentally in the 1970s, before its gut microbial functions became a major research focus.\n\nSCFA metabolism itself also influences signaling. Acetyl-CoA availability can affect acetylation reactions, while changes in oxidation alter cellular energy balance and redox state. An often-discussed example is the “butyrate paradox”: normal differentiated colonocytes may rapidly oxidize butyrate, whereas some highly glycolytic tumor cells metabolize it differently, allowing stronger intracellular accumulation and enzyme inhibition. This is a context-dependent experimental framework, not evidence that butyrate has one predictable effect on every intestinal cell or tumor."
    },
    {
      "heading": "Epithelial, immune, and endocrine functions",
      "text": "Within the colon, butyrate oxidation links microbial fermentation to epithelial energy supply. Mitochondrial oxygen consumption by epithelial cells helps maintain the steep oxygen gradient between vascularized host tissue and the largely anaerobic intestinal lumen. Animal and cell studies have connected this metabolism with hypoxia-responsive pathways and maintenance of conditions favorable to obligate anaerobes. The relationship is reciprocal: the microbial community produces butyrate, while host use of that butyrate helps shape the microbial habitat.\n\nSCFAs can influence epithelial barrier properties, including tight-junction organization, mucus-related processes, and antimicrobial responses. These findings do not imply that larger doses always produce a stronger barrier. In intact tissue, differentiated surface cells consume much of the butyrate before it reaches the proliferative cells deeper in colonic crypts. Experimental injury can change this exposure pattern. Work in animal models has shown that butyrate reaching exposed stem or progenitor cells can suppress proliferation, demonstrating why location and tissue architecture matter alongside concentration.\n\nImmune effects involve both surface receptors and intracellular mechanisms. Studies published in 2013 established that microbial metabolites, particularly butyrate and propionate, could influence the differentiation or accumulation of colonic regulatory T cells in mice. These cells contribute to immune tolerance. Proposed and demonstrated mechanisms include altered histone acetylation at regulatory regions and signaling through SCFA-responsive receptors. Effects vary across experimental systems, and the extensive animal evidence should be distinguished from the more limited ability to measure equivalent causal processes directly in humans.\n\nOther affected populations include neutrophils, macrophages, and dendritic cells. SCFAs can modify chemotaxis, activation, and cytokine production. These are not uniformly suppressive actions: recruitment of immune cells and restriction of excessive inflammatory signaling can occur under different conditions. Consequently, describing SCFAs simply as “anti-inflammatory” obscures their participation in both host defense and regulation of inflammation.\n\nIn the endocrine system, SCFA-sensitive intestinal L cells can secrete peptide YY and glucagon-like peptide-1, or GLP-1. These hormones participate in intestinal motility, nutrient handling, and communication with other organs. Receptor experiments and some human interventions support a connection between colonic fermentation and enteroendocrine secretion, but changes in hormone concentrations do not by themselves establish durable effects on body weight or metabolic disease.\n\nConnections with the brain are studied through neural, immune, endocrine, and metabolic pathways, often grouped under the gut–brain axis. Some circulating SCFAs can reach tissues beyond the intestine, but direct brain exposure differs sharply from colonic exposure. Behavioral changes in germ-free animals or animals receiving high-dose SCFAs cannot be attributed automatically to a single normal physiological signaling route. The transport pathway, dose, and intermediate host responses remain central to interpreting such experiments."
    },
    {
      "heading": "Human health research and limits of causal interpretation",
      "text": "Human studies investigate SCFAs in relation to bowel physiology, metabolic regulation, inflammatory disorders, and cancer. Much of this work begins with associations among diet, microbial composition, and metabolite concentrations. Such observations can identify patterns but do not establish whether an SCFA causes a physiological change. Disease itself may alter appetite, transit time, oxygen availability, medication exposure, and microbial substrate supply, all of which can change the measured SCFA profile.\n\nDietary interventions illustrate the difficulty of isolating one mechanism. Increasing fermentable fiber can alter stool bulk, water retention, transit, bile-acid metabolism, and numerous microbial products in addition to SCFAs. Different fibers are not metabolically interchangeable: inulin-type fructans, resistant starches, and arabinoxylans differ in structure and accessibility to microbial enzymes. Participants also differ in their resident organisms and metabolic capacities. A similar dietary intervention may therefore produce different SCFA responses in different people.\n\nMore targeted studies have used direct colonic administration, rectal preparations, or chemically modified substrates designed to release an SCFA in the large intestine. Inulin–propionate ester, for example, has been investigated as a means of increasing colonic propionate delivery. These approaches improve control over exposure but introduce their own interpretive issues. The carrier substrate may have independent effects, release may vary, and the resulting concentration profile may not reproduce gradual endogenous production. A randomized controlled trial can test a defined intervention, but it does not necessarily establish the effects of every food or microorganism associated with that metabolite.\n\nIn inflammatory bowel disease research, altered butyrate-producing communities and altered epithelial metabolism have both received attention. Local SCFA administration has been examined, including in conditions involving defunctioned segments of colon, but findings across clinical settings are not uniformly consistent. Changes in microbial abundance, metabolite availability, and host utilization can occur simultaneously. A reduced abundance of a putative butyrate producer is therefore not sufficient to identify a single biochemical deficiency or demonstrate that replacing the metabolite will change disease activity.\n\nColorectal cancer research likewise distinguishes experimental mechanisms from clinical outcomes. Butyrate can alter proliferation, differentiation, and cell death in cultured tumor cells, while animal studies show dependence on diet, microbial context, host genotype, and disease model. Evidence concerning fiber-rich diets cannot be assigned entirely to butyrate, because such diets differ in many other respects. Neither a fecal butyrate measurement nor the presence of a particular bacterial taxon is an established stand-alone indicator of cancer risk.\n\nCirculating and fecal SCFAs are also investigated as biomarkers, but proposed signatures face substantial biological and analytical variability. Stronger causal evidence combines controlled interventions, direct exposure measurements, metabolic tracing, and reproducible clinical outcomes. Distinguishing production from absorption and local action from systemic exposure is especially important when comparing observational human findings with mechanistic laboratory experiments."
    },
    {
      "heading": "Measurement and experimental methods",
      "text": "SCFA analysis begins with defining the sample and the quantity of interest. Feces, intestinal contents, portal blood, peripheral blood, tissue extracts, and microbial culture medium represent different compartments. A concentration, a total pool size, and a production rate are different measurements. Reporting micromoles per gram of wet feces, for example, incorporates water content, whereas normalization to dry mass answers a somewhat different question. Neither measurement directly provides the daily amount produced throughout the colon.\n\nPreanalytical handling can substantially alter results. Microorganisms may continue fermenting after collection, while volatile compounds can be lost during storage and processing. Temperature, delay before stabilization, freeze–thaw cycles, extraction pH, and container conditions all matter. Blood measurements are especially demanding because some SCFAs occur at low concentrations and acetate contamination can arise from materials or reagents. Method validation must therefore include blanks, recovery experiments, and stability assessment rather than relying only on instrument sensitivity.\n\nGas chromatography, coupled either to flame-ionization detection or to mass spectrometry, is widely used. Samples may be acidified and extracted, analyzed by headspace methods, or chemically derivatized to improve separation and detection. Liquid chromatography–mass spectrometry often employs derivatization because small, polar carboxylic acids can otherwise be difficult to retain and distinguish. Nuclear magnetic resonance spectroscopy can measure several metabolites simultaneously with relatively limited sample manipulation, although sensitivity is generally lower than that of targeted mass-spectrometric methods.\n\nAccurate quantification requires suitable standards, calibration, and attention to matrix effects. Stable-isotope-labeled internal standards can compensate for losses during extraction and changes in detector response, provided they are introduced at the appropriate stage. Analytical methods must also resolve compounds with similar properties. Straight-chain butyrate and branched-chain isobutyrate have the same molecular formula but different structures; identifying them requires chromatographic or other distinguishing information, not molecular mass alone.\n\nStable-isotope tracing addresses questions that concentration measurements cannot. Labeled substrates can track carbon from a fermentable carbohydrate into individual SCFAs, expired carbon dioxide, or downstream host metabolites. Interpretation requires accounting for dilution by unlabeled pools, microbial cross-feeding, absorption, and first-pass metabolism. Isotope-based estimates of production or systemic availability are therefore model-dependent, but they provide a more direct view of carbon flow than a single stool sample.\n\nExperimental platforms include anaerobic batch cultures, continuous gut simulators, germ-free and defined-community animals, and intestinal organoids. Each resolves different aspects of the problem. Culture systems permit controlled substrate and community manipulation but omit much host physiology; organoids represent epithelial responses but may lack circulation, immune cells, and normal luminal gradients. Metagenomics identifies potential pathway genes, while RNA, protein, and metabolite measurements provide complementary evidence about activity. Gene abundance alone cannot establish the rate of SCFA production."
    },
    {
      "heading": "Ruminant nutrition, environmental cycling, and practical uses",
      "text": "In cattle, sheep, and other ruminants, microbial fermentation in the rumen is a central component of normal nutrition rather than primarily a salvage pathway for material escaping small-intestinal digestion. Microbial communities break down plant polysaccharides, including cellulose, and produce volatile fatty acids that are absorbed through the rumen wall. These acids supply a major share of the animal’s usable energy. Rumen fermentation also produces gases, including carbon dioxide and methane, linking feed utilization to broader carbon flows.\n\nThe main acids have distinct roles in ruminant metabolism. Acetate is an important substrate for lipid synthesis, including mammary fat synthesis. Propionate supplies carbon for hepatic glucose production, which is particularly important because much dietary carbohydrate has already been fermented before reaching the small intestine. A substantial portion of absorbed butyrate is converted by rumen epithelial tissue into ketone bodies, especially beta-hydroxybutyrate. Rumen epithelial metabolism therefore changes the chemical form in which some fermentation-derived energy reaches the circulation.\n\nFeed composition influences both the quantity and proportions of fermentation products. Fiber-rich diets generally favor a higher acetate-to-propionate ratio than diets rich in readily fermentable starch, although the response depends on processing, intake, adaptation, and microbial ecology. Rapid acid production can exceed buffering and removal capacity, lowering rumen pH. Lactate can become important under some conditions, so ruminal acidification cannot be understood from SCFA concentrations alone. This illustrates a broader distinction between the nutritional value of fermentation products and the consequences of their rate of accumulation.\n\nIn sediments, digesters, and other oxygen-poor environments, short-chain organic acids are intermediates in decomposition. Fermenters release acetate, propionate, and butyrate from more complex organic matter. Subsequent organisms consume them through processes that may depend on sulfate reduction, iron reduction, or methane formation. Propionate and butyrate oxidation can require syntrophic partners that maintain sufficiently low concentrations of hydrogen or formate. Their feasibility is governed by thermodynamics and the actual concentrations of reactants and products.\n\nThese relationships are used in anaerobic digestion and wastewater treatment. Accumulation of volatile fatty acids may indicate an imbalance between acid production and downstream consumption, particularly by methane-producing archaea. In enhanced biological phosphorus removal, acetate and propionate provide carbon for organisms that store intracellular polymers and subsequently accumulate phosphorus. Some industrial processes instead aim to recover the acids themselves from organic wastes as feedstocks for chemicals and biodegradable polymers.\n\nAcetic acid and propionic acid also have established food and industrial uses. Acetate is central to vinegar production, while propionic acid and propionate salts are used to inhibit molds in suitable food and feed applications. Undissociated weak acids can enter microbial cells and disrupt intracellular pH and metabolic balance, although sensitivity varies among organisms and conditions. Historically, the same chemistry that gave fermented products their acidity and preservation properties later made SCFAs useful probes of microbial metabolism, epithelial nutrition, and interspecies exchange."
    }
  ],
  "links": [
    "fermentation",
    "proton",
    "acid-base-reaction",
    "ph",
    "water",
    "temperature",
    "dietary-fiber",
    "starch",
    "energy",
    "bacteria",
    "glycolysis",
    "adenosine-triphosphate",
    "ammonia",
    "cell-membrane",
    "diffusion",
    "citric-acid-cycle",
    "metabolism",
    "gluconeogenesis",
    "chromatin",
    "gene-expression",
    "regulatory-t-cell",
    "immune-tolerance",
    "neutrophil",
    "macrophage",
    "dendritic-cell",
    "cytokine",
    "inflammation",
    "brain",
    "cancer",
    "randomized-controlled-trial",
    "biomarker",
    "chromatography",
    "mass-spectrometry",
    "nuclear-magnetic-resonance",
    "calibration",
    "isotope",
    "metagenomics",
    "cellulose",
    "methane",
    "thermodynamics",
    "anaerobic-digestion",
    "archaea"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}